Review of the biological properties and toxicity of usnic acid

Natural Product Research

Volumn 29, Issue 23, 2015, Pages 2167-2180

  Araujo A A S ^a   De Melo, M G D ^a   Rabelo, T K ^b   Nunes, P S ^a   Santos, S L ^a   Serafini, M R ^a   Santos, M R V ^a   Quintans, L J ^a   Gelain, D P ^a  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

antimicrobial; antioxidant; biological activity; lichen; usnic acid

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; OXACILLIN; USNIC ACID; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BENZOFURAN DERIVATIVE;

ACUTE LUNG INJURY; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIVIRAL ACTIVITY; ASCITES TUMOR; BIOLOGICAL ACTIVITY; CARDIOVASCULAR EFFECT; CONTACT ALLERGY; CYTOTOXICITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HUMAN; LEISHMANIASIS; LICHEN (ORGANISM); LIVER TOXICITY; NONHUMAN; RADIATION PROTECTION; REVIEW; STOMACH ULCER; ULTRAVIOLET B RADIATION; WOUND HEALING; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BENZOFURANS; HUMANS; LICHENS; MOLECULAR STRUCTURE;

EID: 84942364328     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2015.1007455     Document Type: Review

References (75)

1. Al-Bekairi AM, Qureshi S, Chaudhry MA, Krishna DR, Shah AH. 1991. Mitodepressive, clastogenic and biochemical effects of (+)-usnic acid in mice. J Ethnopharmacol. 33:217-220. doi:10.1016/0378-8741(91)90079-S.
2. Bačkorová M, Bačkor M, Mikeš J, Jendželovský R, Fedoročko P. 2011. Variable responses of different human cancer cells to the lichen compounds parietin, atranorin, usnic acid and gyrophoric acid. Toxicol In Vitro. 25:37-44. doi:10.1016/j.tiv.2010.09.004.
3. Bačkorová M, Jendželovský R, Kello M, Bačkor M, Mikeš J, Fedoročko P. 2012. Lichen secondary metabolites are responsible for induction of apoptosis in HT-29 and A2780 human cancer cell lines. Toxicol In Vitro. 26:462-468. doi:10.1016/j.tiv.2012.01.017.
4. Behera BC, Mahadik N, Morey M. 2012. Antioxidative and cardiovascular-protective activities of metabolite usnic acid and psoromic acid produced by lichen species Usnea complanata under submerged fermentation. Pharm Biol. 50:968-979. doi:10.3109/13880209.2012.654396.
5. Bézivin C, Tomasi S, Rouaud I, Delcros JG, Boustie J. 2004. Cytotoxic activity of compounds from the lichen: Cladonia convoluta. Planta Med. 70:874-877. doi:10.1055/s-2004-827240.
6. Bissell DM, Gores GJ, Laskin DL, Hoofnagle JH. 2001. Drug-induced liver injury: mechanisms and test systems. Hepatology (Baltimore, MD). 33:1009-1013. doi:10.1053/jhep.2001.23505.
7. Boelsterli UA, Lim PL. 2007. Mitochondrial abnormalities-a link to idiosyncratic drug hepatotoxicity? Toxicol Appl Pharmacol. 220:92-107. doi:10.1016/j.taap.2006.12.013.
8. Bomfim RR, Araujo AAS, Cuadros-Orellana S, Melo MGD, Quintans LJ, Cavalcanti SCH. 2009. Larvicidal activity of Cladonia substellata extract and usnic acid against Aedes aegypti and Artemia salina. Lat Am J Pharm. 28:580-584.
9. Brisdelli F, Perilli M, Sellitri D, Piovano M, Garbarino JA, Nicoletti M, Bozzi A, Amicosante G, Celenza G. 2012. Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study. Phytother Res. 25:431-437.
10. Brisdelli F, Perilli M, Sellitri D, Piovano M, Garbarino JA, Nicoletti M, Bozzi A, Amicosante G, Celenza G. 2013. Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study. Phytother Res: PTR. 27:431-437. doi:10.1002/ptr.4739.
11. Bruno M, Trucchi B, Burlando B, Ranzato E, Martinotti S, Akkol EK, Süntar I, Keleş H, Verotta L. 2013. (+)-Usnic acid enamines with remarkable cicatrizing properties. Bioorg Med Chem. 21:1834-1843. doi:10.1016/j.bmc.2013.01.045.
12. Campanella L, Delfini M, Ercole P, Iacoangeli A, Risuleo G. 2002. Molecular characterization and action of usnic acid: a drug that inhibits proliferation of mouse polyomavirus in vitro and whose main target is RNA transcription. Biochimie. 84:329-334. doi:10.1016/S0300-9084(02)01386-X.
13. Cardarelli M, Serino G, Campanella L, Ercole P, De Cicco Nardone F, Alesiani O, Rossiello F. 1997. Antimitotic effects of usnic acid on different biological systems. Cell Mol Life Sci. 53:667-672. doi:10.1007/s000180050086.
14. Cocchietto M, Skert N, Nimis PL, Sava G. 2002. A review on usnic acid, an interesting natural compound. Die Naturwissenschaften. 89:137-146. doi:10.1007/s00114-002-0305-3.
15. da Silva Santos NP, Nascimento SC, Wanderley MS, Pontes-Filho NT, da Silva JF, de Castro CM, Pereira EC, da Silva NH, Honda NK, Santos-Magalhaes NS. 2006. Nanoencapsulation of usnic acid: an attempt to improve antitumour activity and reduce hepatotoxicity. Eur J Pharm Biopharm. 64:154-160. doi:10.1016/j.ejpb.2006.05.018.
16. De Carvalho EAB, Andrade PP, Silva NH, Pereira EC, Figueiredo RCBQ. 2005. Effect of usnic acid from the lichen Cladonia substellata on Trypanosoma cruzi in vitro: an ultrastructural study. Micron. 36:155-161. doi:10.1016/j.micron.2004.09.003.
17. Durazo FA, Lassman C, Han SHB, Saab S, Lee NP, Kawano M, Saggi B, Gordon S, Farmer DG, Yersiz H, et al. 2004. Fulminant liver failure due to usnic acid for weight loss. Amer J Gastroenterol. 99:950-952. doi:10.1111/j.1572-0241.2004.04165.x.
18. Dykens JA, Jamieson JD, Marroquin LD, Nadanaciva S, Xu JJ, Dunn MC, Smith AR, Will Y. 2008. In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone. Toxicol Sci. 103:335-345. doi:10.1093/toxsci/kfn056.
19. Dykens JA, Will Y. 2007. The significance of mitochondrial toxicity testing in drug development. Drug Disc Today. 12:777-785.
20. Elo H, Matikainen J, Pelttari E. 2007. Potent activity of the lichen antibiotic (+)-usnic acid against clinical isolates of vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. Die Naturwissenschaften. 94:465-468. doi:10.1007/s00114-006-0208-9.
21. Favreau JT, Ryu ML, Braunstein G, Orshansky G, Park SS, Coody GL, Love LA, Fong TL. 2002. Severe hepatotoxicity associated with the dietary supplement LipoKinetix. Ann Int Med. 136:590-595. doi:10.7326/0003-4819-136-8-200204160-00008.
22. Fernandes VA. 2013. Avaliação do efeito do tratamento com ácido úsnico sobre o perfil redox cardíaco e em parâmetros da função cardíaca na doença de Chagas. Federal University of Sergipe.
23. Foti RS, Dickmann LJ, Davis JA, Greene RJ, Hill JJ, Howard ML, Pearson JT, Rock DA, Tay JC, Wahlstrom JL, Slatter JG. 2008. Metabolism and related human risk factors for hepatic damage by usnic acid containing nutritional supplements. Xenobiotica. 38:264-280. doi:10.1080/00498250701802514.
24. Fournet A, Ferreira ME, deArias AR, deOrtiz ST, Inchausti A, Yaluff G, Quilhot W, Fernandez E, Hidalgo ME. 1997. Activity of compounds isolated from Chilean lichens against experimental cutaneous leishmaniasis. Comp Biochem Phys C. 116:51-54.
25. Halici M, Odabasoglu F, Suleyman H, Cakir A, Aslan A, Bayir Y. 2005. Effects of water extract of Usnea longissima on antioxidant enzyme activity and mucosal damage caused by indomethacin in rats. Phytomedicine. 12:656-662. doi:10.1016/j.phymed.2004.06.021.
26. Halliwell B. 2008. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch Biochem Biophys. 476:107-112. doi:10.1016/j.abb.2008.01.028.
27. Han D, Matsumaru K, Rettori D, Kaplowitz N. 2004. Usnic acid-induced necrosis of cultured mouse hepatocytes: inhibition of mitochondrial function and oxidative stress. Biochem Pharmacol. 67:439-451. doi:10.1016/j.bcp.2003.09.032.
28. Huang Z, Zheng G, Tao J, Ruan J. 2011. Anti-inflammatory effects and mechanisms of usnic acid. J Wuhan Univ Technol Mater. 26:955-959. doi:10.1007/s11595-011-0344-8.
29. Ingólfsdóttir K. 2002. Usnic acid[J]. Phytochemistry. 61:729-736.
30. Joseph A, Lee T, Moland CL, Branham WS, Fuscoe JC, Leakey JE, Allaben WT, Lewis SM, Ali AA, Desai VG. 2009. Effect of (+)-usnic acid on mitochondrial functions as measured by mitochondria-specific oligonucleotide microarray in liver of B6C3F1 mice. Mitochondrion. 9:149-158. doi:10.1016/j.mito.2009.02.002.
31. Kohlhardt-Floehr C, Boehm F, Troppens S, Lademann J, Truscott TG. 2010. Prooxidant and antioxidant behaviour of usnic acid from lichens under uvb-light irradiation - studies on human cells. J Photochem Photobiol B, Biol. 101:97-102. doi:10.1016/j.jphotobiol.2010.06.017.
32. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE. 2009. Mitochondria and reactive oxygen species. Free Rad Biol Med. 47:333-343. doi:10.1016/j.freeradbiomed.2009.05.004.
33. Krishna YR, Mittal V, Grewal P, Fiel M, Schiano T. 2011. Acute liver failure caused by 'fat burners' and dietary supplements: A case report and literature review. Can J Gastroenterol. 25:157-160.
34. Kumar KC, Müller K. 1999a. Lichen metabolites. 1. Inhibitory action against leukotriene b 4 biosynthesis by a non-redox mechanism. J Nat Prod. 62:817-820. doi:10.1021/np9803777.
35. Kumar kc KC, Müller K. 1999b. Lichen metabolites. 2. Antiproliferative and cytotoxic activity of gyrophoric, usnic, and diffractaic acid on human keratinocyte growth. J Nat Prod. 62:821-823. doi:10.1021/np980378z.
36. Lauterwein M, Oethinger M, Belsner K, Peters T, Marre R. 1995. In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms. Antimicrob Agents Chemother. 39:2541-2543. doi:10.1128/AAC.39.11.2541.
37. Lee WM. 2003. Drug-induced hepatotoxicity. New Engl J Med. 349:474-485. doi:10.1056/NEJMra021844.
38. Lira MCB, Siqueira-Moura MP, Rolim-Santos HML, Galetti FCS, Simioni AR, Santos NP, Do Egito EST, Silva CL, Tedesco AC, Santos-Magalhaes NS. 2009. In vitro uptake and antimycobacterial activity of liposomal usnic acid formulation. J Liposome Res. 19:49-58.
39. Lisci M, Monte M, Pacini E. 2003. Lichens and higher plants on stone: a review. Int Biodeterior Biodegrad. 51:1-17. doi:10.1016/S0964-8305(02)00071-9.
40. Manojlovic NT, Vasiljevic PJ, Maskovic PZ, Juskovic M, Bogdanovic-Dusanovic G. 2012. Chemical composition, antioxidant, and antimicrobial activities of lichen Umbilicaria cylindrica (L.) Delise (Umbilicariaceae). Evid Based Complement Alternat Med. 2012:1-8. doi:10.1155/2012/452431.
41. Mayer M, O'Neill MA, Murray KE, Santos-Magalhães NS, Carneiro-Leão AM, Thompson AM, Appleyard VC. 2005. Usnic acid: a non-genotoxic compound with anti-cancer properties. Anti-cancer Drugs. 16:805-809. doi:10.1097/01.cad.0000175588.09070.77.
42. Melo MG, dos Santos JPA, Serafini MR, Caregnato FF, de Bittencourt Pasquali MA, Rabelo TK, da Rocha RF, Quintans L, Jr., de Souza Araújo AA, da Silva FA, Fonseca Moreira JC,, Gelain PN. 2011. Redox properties and cytoprotective actions of atranorin, a lichen secondary metabolite. Toxicol In Vitro. 25:462-468. doi:10.1016/j.tiv.2010.11.014.
43. Mendonça SCS. 2009. Efeito do ácido úsnico obtido do líquen Cladonia substellata Vainio sobre a contratilidade do átrio esquerdo de cobaia (Cavia porcellus). Federal of Sergipe University.
44. Mitchell JC, Shibata S. 1969. Immunologic activity of some substances derived from Lichenized Fungi. J Investigative Dermatology. 52:517-520. doi:10.1038/jid.1969.88.
45. Neff GW, Reddy KR, Durazo FA, Meyer D, Marrero R, Kaplowitz N. 2004. Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid. J Hepatol. 41:1062-1064. doi:10.1016/j.jhep.2004.06.028.
46. Nunes PS, Albuquerque Jr., RLC, Cavalcante DRR, Dantas MDM, Cardoso JC, Bezerra SMS, Souza JCC, Serafini MR, Quitans Jr., LJ, Bonjardim LR, Araújo AS. 2011. Collagen-based films containing liposome-loaded usnic acid as dressing for dermal burn healing. J Biomed Biotechnol. 2011:1-9. doi:10.1155/2011/761593.
47. Odabasoglu F, Cakir A, Suleyman H, Aslan A, Bayir Y, Halici M, Kazaz C. 2006. Gastroprotective and antioxidant effects of usnic acid on indomethacin-induced gastric ulcer in rats. J Ethnopharmacol. 103:59-65. doi:10.1016/j.jep.2005.06.043.
48. Okuyama E, Umeyama K, Yamazaki M, Kinoshita Y, Yamamoto Y. 1995. Usnic acid and diffractaic acid as analgesic and antipyretic components of usnea diffracta. Planta Med. 61:113-115. doi:10.1055/s-2006-958027.
49. O'Neill MA, Mayer M, Murray KE, Rolim-Santos HM, Santos-Magalhães NS, Thompson AM, Appleyard VC. 2010. Does usnic acid affect microtubules in human cancer cells? Brazil J Biol. 70:659-664. doi:10.1590/S1519-69842010005000013.
50. Pires RH, Lucarini R, Mendes-Giannini MJS. 2012. Effect of usnic acid on Candida orthopsilosis and C. parapsilosis. Antimicrob Agents Chemother. 56:595-597. doi:10.1128/AAC.05348-11.
51. Pramyothin P. 1986. Isolated liver cell preparations. J Natl Res Council. 18:1-9.
52. Pramyothin P, Janthasoot W, Pongnimitprasert N, Phrukudom S, Ruangrungsi N. 2004. Hepatotoxic effect of (+)usnic acid from UsneasiamensisWainio in rats, isolated rat hepatocytes and isolated rat liver mitochondria. J Ethnopharmacol. 90:381-387.
53. Rabelo TK, Zeidán-Chuliá F, Vasques LM, dos Santos JPA, da Rocha RF, Pasquali MAdB, Rybarczyk-Filho JL, Araújo AAS, Moreira JCF, Gelain DP. 2012. Redox characterization of usnic acid and its cytotoxic effect on human neuron-like cells (SH-SY5Y). Toxicol In Vitro. 26:304-314. doi:10.1016/j.tiv.2011.12.003.
54. Rafanelli S, Bacchillga R, Stanganelli I, Rafanelli A. 1995. Contact dermatitis from usnic acid in vaginal ovules. Contact Dermatitis. 33:271-271. doi:10.1111/j.1600-0536.1995.tb00484.x.
55. Ramos DF, da silva PEA. 2010. Antimycobacterial activity of usnic acid against resistant and susceptible strains of Mycobacterium tuberculosis and non-tuberculous mycobacteria. Pharm Biology. 48:260-263. doi:10.3109/13880200903085490.
56. Rancan F, Rosan S, Boehm K, Fernández E, Hidalgo ME, Quihot W, Rubio C, Boehm F, Piazena H, Oltmanns U. 2002. Protection against UVB irradiation by natural filters extracted from lichens. J Photochem Photobiol B. 68:133-139. doi:10.1016/S1011-1344(02)00362-7.
57. Ribeiro-Costa RM, Alves AJ, Santos NP, Nascimento SC, Gonçalves EC, Silva NH, Honda NK, Santos-Magalhães NS. 2004. In vitro and in vivo properties of usnic acid encapsulated into PLGA-microspheres. J Microencapsul. 21:371-384. doi:10.1080/02652040410001673919.
58. Rice-Evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB. 1995. The relative antioxidant of plant-derived polyphenolic flavonoids. Free Rad Res. 22:375-383. doi:10.3109/10715769509145649.
59. Riella KR, Marinho RR, Santos JS, Pereira-Filho RN, Cardoso JC, Albuquerque-Junior RL, Thomazzi SM. 2012. Anti-inflammatory and cicatrizing activities of thymol, a monoterpene of the essential oil from Lippia gracilis, in rodents. J Ethnopharmacol. 143:656-663. doi:10.1016/j.jep.2012.07.028.
60. Sahu SC, O'Donnell, Jr, MW, Sprando RL. 2012. Interactive toxicity of usnic acid and lipopolysaccharides in human liver HepG2 cells. J Appl Toxicol. 32:739-749. doi:10.1002/jat.2768.
61. Salo H, Hannuksela M, Hausen B. 1981. Lichen picker's dermatitis (cladonia alpestris (l) rab.). Contact Dermatitis. 7:9-13. doi:10.1111/j.1600-0536.1981.tb03951.x.
62. Sanchez W, Maple JT, Burgart LJ, Kamath PS. 2006. Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid. Mayo Clin Proc. 81:541-544. doi:10.4065/81.4.541.
63. Santos NPS, Nascimento SC, Wanderley MSO, Pontes-Filho NT, Silva JF, Castro CMMB, Pereira EC, Silva NH, Honda NK, Santos-Magalhães NS. 2006. Nanoencapsulation of usnic acid: An attempt to improve antitumour activity and reduce hepatotoxicity. Eur J Pharm Biopharm. 64:154-160.
64. Scalbert A, Johnson IT, Saltmarsh M. 2005. Polyphenols: antioxidants and beyond. Am J Clin Nutr. 81:215S-217S.
65. Segatore B, Bellio P, Setacci D, Brisdelli F, Piovano M, Garbarino JA, Nicoletti M, Amicosante G, Perilli M, Celenza G. 2012. In vitro interaction of usnic acid in combination with antimicrobial agents against methicillin-resistant Staphylococcus aureus clinical isolates determined by FICI and de model methods. Phytomedicine. 19:341-347. doi:10.1016/j.phymed.2011.10.012.
66. Seifried HE, Anderson DE, Fisher EI, Milner JA. 2007. A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem. 18:567-579. doi:10.1016/j.jnutbio.2006.10.007.
67. Sheu M, Simpson EL, Law SV, Storrs FJ. 2006. Allergic contact dermatitis from a natural deodorant: a report of 4 cases associated with lichen acid mix allergy. J Amer Acad Dermatol. 55:332-337. doi:10.1016/j.jaad.2004.12.043.
68. Sokolov DN, Zarubaev VV, Shtro AA, Polovinka MP, Luzina OA, Komarova NI, Salakhutdinov NF, Kiselev OI. 2012. Anti-viral activity of (-)- and (+)-usnic acids and their derivatives against influenza virus A(H1N1)2009. Bioorg Med Chem Lett. 22:7060-7064. doi:10.1016/j.bmcl.2012.09.084.
69. Song Y, Dai F, Zhai D, Dong Y, Zhang J, Lu B, Luo J, Liu M, Yi Z. 2012. Usnic acid inhibits breast tumor angiogenesis and growth by suppressing VEGFR2-mediated AKT and ERK1/2 signaling pathways. Angiogenesis. 15:421-432. doi:10.1007/s10456-012-9270-4.
70. Sonko BJ, Schmitt TC, Guo L, Shi Q, Boros LG, Leakey JE, Beger RD. 2011. Assessment of usnic acid toxicity in rat primary hepatocytes using 13c isotopomer distribution analysis of lactate, glutamate and glucose. Food Chem Toxicol. 49:2968-2974. doi:10.1016/j.fct.2011.07.047.
71. Su Z-Q, Mo Z-Z, Liao J-B, Feng X-X, Liang Y-Z, Zhang X, Liu Y-H, Chen X-Y, Chen Z-W, Su Z-R, Lai X-P. 2014. Usnic acid protects LPS-induced acute lung injury in mice through attenuating inflammatory responses and oxidative stress. Inter Immunopharmacology 22: 371-378.
72. Takai M, Uehara Y, Beisler JA. 1979. Usnic acid derivatives as potential antineoplastic agents. J Med Chem. 22:1380-1384. doi:10.1021/jm00197a019.
73. Thune PO, Solberg YJ. 1980. Photosensitivity and allergy to aromatic lichen acids, compositae oleoresins and other plant substances. Compositae oleoresins and other plant substances. Contact Dermatitis. 6:81-87. doi:10.1111/j.1600-0536.1980.tb03911.x.
74. Vijayakumar CS, Viswanathan S, Reddy MK, Parvathavarthini S, Kundu AB, Sukumar E. 2000. Anti-inflammatory activity of (+)-usnic acid. Fitoterapia. 71:564-566. doi:10.1016/S0367-326X(00)00209-4.
75. Yellapu RK, Mittal V, Grewal P, Fiel M, Schiano T. 2011. Acute liver failure caused by 'fat burners' and dietary supplements: a case report and literature review. Can J Gastroenterol. 25:157-160.